Tags: US | Bristol | Myers | Strategy

Bristol-Myers: 60 Drugs in Testing to Boost Sales

Thursday, 04 Mar 2010 01:24 PM

 

  Comment  |
   Contact  |
  Print  
|  A   A  
  Copy Shortlink

Executives at drugmaker Bristol-Myers Squibb Co. are telling analysts at a business briefing they have 60 potential drugs in development, seven in late-stage studies.

The company says it expects future revenue from those medicines and growing sales from existing drugs to help offset an expected plunge in Plavix sales in 2012. That's when U.S. generic competition will start slashing sales of the $6 billion-a-year blood thinner, the world's second-best-selling drug.

The New York-based company's strategy aims to replace that revenue with new drug sales to maintain profits. Bristol-Myers forecasts earnings per share in 2013 will be at least $1.95, a little more than analysts expect.

The business briefing comes two days after news of a CEO change.

© Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  Comment  |
   Contact  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Full Holiday Menu for Obamas, Plus 6 Pies

Thursday, 27 Nov 2014 20:59 PM

President Barack Obama spent a quiet Thanksgiving at the White House where the belly-stuffing menu featured all the holi . . .

NFL Urges Lame-Duck Congress to Renew Terrorism Risk Insurance

Thursday, 27 Nov 2014 20:21 PM

The National Football League has joined a growing coalition of business groups across the country to urge Congress to pa . . .

Alaska Pot Backer Ordered to Comply With Subpoena

Thursday, 27 Nov 2014 19:11 PM

A campaign-finance investigation is moving forward against an Alaska television reporter who quit her job on-air and vow . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved